Loading…

A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)

To reveal the relationship between hypodiploidy with 30 to 39 chromosomes and near-triploidy in acute lymphoblastic leukemia (ALL), we studied 24 patients presenting with one of these aneuploidies among 623 adults with ALL registered in the Leucémie Aigüe Lymphoblastique de l'Adulte (LALA) prot...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2004-10, Vol.104 (8), p.2444-2451
Main Authors: Charrin, Christiane, Thomas, Xavier, Ffrench, Martine, Le, Quoc-Hung, Andrieux, Joris, Mozziconacci, Marie-Joelle, Laï, Jean-Luc, Bilhou-Nabera, Chrystele, Michaux, Lucienne, Bernheim, Alain, Bastard, Christian, Mossafa, Hossein, Perot, Christine, Maarek, Odile, Boucheix, Claude, Lheritier, Véronique, Delannoy, André, Fière, Denis, Dastugue, Nicole
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c426t-b081e721240871ce15ba653731ce4355336c1adb97db7cab64fe658ac579dacf3
cites
container_end_page 2451
container_issue 8
container_start_page 2444
container_title Blood
container_volume 104
creator Charrin, Christiane
Thomas, Xavier
Ffrench, Martine
Le, Quoc-Hung
Andrieux, Joris
Mozziconacci, Marie-Joelle
Laï, Jean-Luc
Bilhou-Nabera, Chrystele
Michaux, Lucienne
Bernheim, Alain
Bastard, Christian
Mossafa, Hossein
Perot, Christine
Maarek, Odile
Boucheix, Claude
Lheritier, Véronique
Delannoy, André
Fière, Denis
Dastugue, Nicole
description To reveal the relationship between hypodiploidy with 30 to 39 chromosomes and near-triploidy in acute lymphoblastic leukemia (ALL), we studied 24 patients presenting with one of these aneuploidies among 623 adults with ALL registered in the Leucémie Aigüe Lymphoblastique de l'Adulte (LALA) protocols. The 2 ploidy groups presented a striking similarity of their cytogenetic profiles: chromosomes 2, 3, 4, 7, 13, 15, 16, and 17, significantly monosomic in hypodiploidy 30 to 39, were also frequently disomic in near-triploidy, whereas those retained in pairs in hypodiploidy 30 to 39 were frequently tetrasomic in near-triploidy. DNA content data revealed the simultaneous presence of 2 aneuploid peaks in most tested cases (DNA indexes: 0.72-0.87/1.39-1.89) and a multiple correspondence analysis applied on cytogenetic profiles ascertained their strong relationship. We thus assumed that near-triploidy derives from the duplication of hypodiploidy with 30 to 39 chromosomes and that both aneuploid groups are 2 expressions of the same disease. These 24 patients presented with B-cell phenotype, low leukocytoses (median white blood cell count, 4.2 × 109/L), and poor prognosis (complete remission, 57%; median disease-free-survival, 8 months; median survival, 10.4 months) comparable to that of Ph+ patients treated according to the same protocol. We suggest that hypodiploidy with 30 to 39 chromosomes or near-triploidy should be regarded as a new high-risk factor in the risk stratification of adult ALL protocols.
doi_str_mv 10.1182/blood-2003-04-1299
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66942739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120433075</els_id><sourcerecordid>66942739</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-b081e721240871ce15ba653731ce4355336c1adb97db7cab64fe658ac579dacf3</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRSMEYoaBH2CBagOCRcCvPDxiE414SZFYAOvIcSrdBscOtgP0n_I5uKdbmh2ruiqde1WqWxRPKXlNacvejNb7qWSE8JKIkjIp7xWXtGJtSQgj94tLQkhdCtnQi-JRjN8JoYKz6mFxQSvCJWvpZfG3g4CrDwnm4BdIe4S-67tSClBuOukvHeyC39YI3sH-sPrJrNab6QC_TdoDJ5A8cAl6nyN89AvGW7NDFcoUzvA1MFh9jGa0CPhnDZi1dzl0BgXRH7cumXQA7d2MIRi3ywYfYA1-53w0EYwDNW02gdJbQrCHZd370aqYjAaL2w9cjIKXXd-_elw8mJWN-OQ8r4pv7999vflY9p8_fLrp-lILVqdyJC3FhlEmSNtQjbQaVV3xhmcteFVxXmuqplE209hoNdZixrpqla4aOSk986vixSk3X_lzw5iGxUSN1iqHfotDXUvBGi4zyE6gDvkLAedhDWZR4TBQMhz7HG77HI59DkQMxz6z6dk5fRsXnO4s5wIz8PwMqKiVnYNy2sQ7rma1kLLO3NsTh_kXvwyGIWqDTuNkAuo0TN78745_mHXAdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66942739</pqid></control><display><type>article</type><title>A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)</title><source>ScienceDirect®</source><creator>Charrin, Christiane ; Thomas, Xavier ; Ffrench, Martine ; Le, Quoc-Hung ; Andrieux, Joris ; Mozziconacci, Marie-Joelle ; Laï, Jean-Luc ; Bilhou-Nabera, Chrystele ; Michaux, Lucienne ; Bernheim, Alain ; Bastard, Christian ; Mossafa, Hossein ; Perot, Christine ; Maarek, Odile ; Boucheix, Claude ; Lheritier, Véronique ; Delannoy, André ; Fière, Denis ; Dastugue, Nicole</creator><creatorcontrib>Charrin, Christiane ; Thomas, Xavier ; Ffrench, Martine ; Le, Quoc-Hung ; Andrieux, Joris ; Mozziconacci, Marie-Joelle ; Laï, Jean-Luc ; Bilhou-Nabera, Chrystele ; Michaux, Lucienne ; Bernheim, Alain ; Bastard, Christian ; Mossafa, Hossein ; Perot, Christine ; Maarek, Odile ; Boucheix, Claude ; Lheritier, Véronique ; Delannoy, André ; Fière, Denis ; Dastugue, Nicole</creatorcontrib><description>To reveal the relationship between hypodiploidy with 30 to 39 chromosomes and near-triploidy in acute lymphoblastic leukemia (ALL), we studied 24 patients presenting with one of these aneuploidies among 623 adults with ALL registered in the Leucémie Aigüe Lymphoblastique de l'Adulte (LALA) protocols. The 2 ploidy groups presented a striking similarity of their cytogenetic profiles: chromosomes 2, 3, 4, 7, 13, 15, 16, and 17, significantly monosomic in hypodiploidy 30 to 39, were also frequently disomic in near-triploidy, whereas those retained in pairs in hypodiploidy 30 to 39 were frequently tetrasomic in near-triploidy. DNA content data revealed the simultaneous presence of 2 aneuploid peaks in most tested cases (DNA indexes: 0.72-0.87/1.39-1.89) and a multiple correspondence analysis applied on cytogenetic profiles ascertained their strong relationship. We thus assumed that near-triploidy derives from the duplication of hypodiploidy with 30 to 39 chromosomes and that both aneuploid groups are 2 expressions of the same disease. These 24 patients presented with B-cell phenotype, low leukocytoses (median white blood cell count, 4.2 × 109/L), and poor prognosis (complete remission, 57%; median disease-free-survival, 8 months; median survival, 10.4 months) comparable to that of Ph+ patients treated according to the same protocol. We suggest that hypodiploidy with 30 to 39 chromosomes or near-triploidy should be regarded as a new high-risk factor in the risk stratification of adult ALL protocols.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2003-04-1299</identifier><identifier>PMID: 15039281</identifier><language>eng</language><publisher>Washington, DC: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aged ; Biological and medical sciences ; Chromosome aberrations ; Chromosomes, Human - genetics ; Diploidy ; Female ; Flow Cytometry ; Hematologic and hematopoietic diseases ; Humans ; Immunophenotyping ; Karyotyping ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical genetics ; Medical sciences ; Middle Aged ; Polyploidy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology ; Prognosis ; Survival Rate ; Treatment Outcome</subject><ispartof>Blood, 2004-10, Vol.104 (8), p.2444-2451</ispartof><rights>2004 American Society of Hematology</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-b081e721240871ce15ba653731ce4355336c1adb97db7cab64fe658ac579dacf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120433075$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16264996$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15039281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Charrin, Christiane</creatorcontrib><creatorcontrib>Thomas, Xavier</creatorcontrib><creatorcontrib>Ffrench, Martine</creatorcontrib><creatorcontrib>Le, Quoc-Hung</creatorcontrib><creatorcontrib>Andrieux, Joris</creatorcontrib><creatorcontrib>Mozziconacci, Marie-Joelle</creatorcontrib><creatorcontrib>Laï, Jean-Luc</creatorcontrib><creatorcontrib>Bilhou-Nabera, Chrystele</creatorcontrib><creatorcontrib>Michaux, Lucienne</creatorcontrib><creatorcontrib>Bernheim, Alain</creatorcontrib><creatorcontrib>Bastard, Christian</creatorcontrib><creatorcontrib>Mossafa, Hossein</creatorcontrib><creatorcontrib>Perot, Christine</creatorcontrib><creatorcontrib>Maarek, Odile</creatorcontrib><creatorcontrib>Boucheix, Claude</creatorcontrib><creatorcontrib>Lheritier, Véronique</creatorcontrib><creatorcontrib>Delannoy, André</creatorcontrib><creatorcontrib>Fière, Denis</creatorcontrib><creatorcontrib>Dastugue, Nicole</creatorcontrib><title>A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)</title><title>Blood</title><addtitle>Blood</addtitle><description>To reveal the relationship between hypodiploidy with 30 to 39 chromosomes and near-triploidy in acute lymphoblastic leukemia (ALL), we studied 24 patients presenting with one of these aneuploidies among 623 adults with ALL registered in the Leucémie Aigüe Lymphoblastique de l'Adulte (LALA) protocols. The 2 ploidy groups presented a striking similarity of their cytogenetic profiles: chromosomes 2, 3, 4, 7, 13, 15, 16, and 17, significantly monosomic in hypodiploidy 30 to 39, were also frequently disomic in near-triploidy, whereas those retained in pairs in hypodiploidy 30 to 39 were frequently tetrasomic in near-triploidy. DNA content data revealed the simultaneous presence of 2 aneuploid peaks in most tested cases (DNA indexes: 0.72-0.87/1.39-1.89) and a multiple correspondence analysis applied on cytogenetic profiles ascertained their strong relationship. We thus assumed that near-triploidy derives from the duplication of hypodiploidy with 30 to 39 chromosomes and that both aneuploid groups are 2 expressions of the same disease. These 24 patients presented with B-cell phenotype, low leukocytoses (median white blood cell count, 4.2 × 109/L), and poor prognosis (complete remission, 57%; median disease-free-survival, 8 months; median survival, 10.4 months) comparable to that of Ph+ patients treated according to the same protocol. We suggest that hypodiploidy with 30 to 39 chromosomes or near-triploidy should be regarded as a new high-risk factor in the risk stratification of adult ALL protocols.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Chromosome aberrations</subject><subject>Chromosomes, Human - genetics</subject><subject>Diploidy</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Karyotyping</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Polyploidy</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology</subject><subject>Prognosis</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp9kcuO1DAQRSMEYoaBH2CBagOCRcCvPDxiE414SZFYAOvIcSrdBscOtgP0n_I5uKdbmh2ruiqde1WqWxRPKXlNacvejNb7qWSE8JKIkjIp7xWXtGJtSQgj94tLQkhdCtnQi-JRjN8JoYKz6mFxQSvCJWvpZfG3g4CrDwnm4BdIe4S-67tSClBuOukvHeyC39YI3sH-sPrJrNab6QC_TdoDJ5A8cAl6nyN89AvGW7NDFcoUzvA1MFh9jGa0CPhnDZi1dzl0BgXRH7cumXQA7d2MIRi3ywYfYA1-53w0EYwDNW02gdJbQrCHZd370aqYjAaL2w9cjIKXXd-_elw8mJWN-OQ8r4pv7999vflY9p8_fLrp-lILVqdyJC3FhlEmSNtQjbQaVV3xhmcteFVxXmuqplE209hoNdZixrpqla4aOSk986vixSk3X_lzw5iGxUSN1iqHfotDXUvBGi4zyE6gDvkLAedhDWZR4TBQMhz7HG77HI59DkQMxz6z6dk5fRsXnO4s5wIz8PwMqKiVnYNy2sQ7rma1kLLO3NsTh_kXvwyGIWqDTuNkAuo0TN78745_mHXAdA</recordid><startdate>20041015</startdate><enddate>20041015</enddate><creator>Charrin, Christiane</creator><creator>Thomas, Xavier</creator><creator>Ffrench, Martine</creator><creator>Le, Quoc-Hung</creator><creator>Andrieux, Joris</creator><creator>Mozziconacci, Marie-Joelle</creator><creator>Laï, Jean-Luc</creator><creator>Bilhou-Nabera, Chrystele</creator><creator>Michaux, Lucienne</creator><creator>Bernheim, Alain</creator><creator>Bastard, Christian</creator><creator>Mossafa, Hossein</creator><creator>Perot, Christine</creator><creator>Maarek, Odile</creator><creator>Boucheix, Claude</creator><creator>Lheritier, Véronique</creator><creator>Delannoy, André</creator><creator>Fière, Denis</creator><creator>Dastugue, Nicole</creator><general>Elsevier Inc</general><general>The Americain Society of Hematology</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041015</creationdate><title>A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)</title><author>Charrin, Christiane ; Thomas, Xavier ; Ffrench, Martine ; Le, Quoc-Hung ; Andrieux, Joris ; Mozziconacci, Marie-Joelle ; Laï, Jean-Luc ; Bilhou-Nabera, Chrystele ; Michaux, Lucienne ; Bernheim, Alain ; Bastard, Christian ; Mossafa, Hossein ; Perot, Christine ; Maarek, Odile ; Boucheix, Claude ; Lheritier, Véronique ; Delannoy, André ; Fière, Denis ; Dastugue, Nicole</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-b081e721240871ce15ba653731ce4355336c1adb97db7cab64fe658ac579dacf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Chromosome aberrations</topic><topic>Chromosomes, Human - genetics</topic><topic>Diploidy</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Karyotyping</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Polyploidy</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology</topic><topic>Prognosis</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Charrin, Christiane</creatorcontrib><creatorcontrib>Thomas, Xavier</creatorcontrib><creatorcontrib>Ffrench, Martine</creatorcontrib><creatorcontrib>Le, Quoc-Hung</creatorcontrib><creatorcontrib>Andrieux, Joris</creatorcontrib><creatorcontrib>Mozziconacci, Marie-Joelle</creatorcontrib><creatorcontrib>Laï, Jean-Luc</creatorcontrib><creatorcontrib>Bilhou-Nabera, Chrystele</creatorcontrib><creatorcontrib>Michaux, Lucienne</creatorcontrib><creatorcontrib>Bernheim, Alain</creatorcontrib><creatorcontrib>Bastard, Christian</creatorcontrib><creatorcontrib>Mossafa, Hossein</creatorcontrib><creatorcontrib>Perot, Christine</creatorcontrib><creatorcontrib>Maarek, Odile</creatorcontrib><creatorcontrib>Boucheix, Claude</creatorcontrib><creatorcontrib>Lheritier, Véronique</creatorcontrib><creatorcontrib>Delannoy, André</creatorcontrib><creatorcontrib>Fière, Denis</creatorcontrib><creatorcontrib>Dastugue, Nicole</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Charrin, Christiane</au><au>Thomas, Xavier</au><au>Ffrench, Martine</au><au>Le, Quoc-Hung</au><au>Andrieux, Joris</au><au>Mozziconacci, Marie-Joelle</au><au>Laï, Jean-Luc</au><au>Bilhou-Nabera, Chrystele</au><au>Michaux, Lucienne</au><au>Bernheim, Alain</au><au>Bastard, Christian</au><au>Mossafa, Hossein</au><au>Perot, Christine</au><au>Maarek, Odile</au><au>Boucheix, Claude</au><au>Lheritier, Véronique</au><au>Delannoy, André</au><au>Fière, Denis</au><au>Dastugue, Nicole</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2004-10-15</date><risdate>2004</risdate><volume>104</volume><issue>8</issue><spage>2444</spage><epage>2451</epage><pages>2444-2451</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>To reveal the relationship between hypodiploidy with 30 to 39 chromosomes and near-triploidy in acute lymphoblastic leukemia (ALL), we studied 24 patients presenting with one of these aneuploidies among 623 adults with ALL registered in the Leucémie Aigüe Lymphoblastique de l'Adulte (LALA) protocols. The 2 ploidy groups presented a striking similarity of their cytogenetic profiles: chromosomes 2, 3, 4, 7, 13, 15, 16, and 17, significantly monosomic in hypodiploidy 30 to 39, were also frequently disomic in near-triploidy, whereas those retained in pairs in hypodiploidy 30 to 39 were frequently tetrasomic in near-triploidy. DNA content data revealed the simultaneous presence of 2 aneuploid peaks in most tested cases (DNA indexes: 0.72-0.87/1.39-1.89) and a multiple correspondence analysis applied on cytogenetic profiles ascertained their strong relationship. We thus assumed that near-triploidy derives from the duplication of hypodiploidy with 30 to 39 chromosomes and that both aneuploid groups are 2 expressions of the same disease. These 24 patients presented with B-cell phenotype, low leukocytoses (median white blood cell count, 4.2 × 109/L), and poor prognosis (complete remission, 57%; median disease-free-survival, 8 months; median survival, 10.4 months) comparable to that of Ph+ patients treated according to the same protocol. We suggest that hypodiploidy with 30 to 39 chromosomes or near-triploidy should be regarded as a new high-risk factor in the risk stratification of adult ALL protocols.</abstract><cop>Washington, DC</cop><pub>Elsevier Inc</pub><pmid>15039281</pmid><doi>10.1182/blood-2003-04-1299</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2004-10, Vol.104 (8), p.2444-2451
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_66942739
source ScienceDirect®
subjects Adolescent
Adult
Aged
Biological and medical sciences
Chromosome aberrations
Chromosomes, Human - genetics
Diploidy
Female
Flow Cytometry
Hematologic and hematopoietic diseases
Humans
Immunophenotyping
Karyotyping
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical genetics
Medical sciences
Middle Aged
Polyploidy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology
Prognosis
Survival Rate
Treatment Outcome
title A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T14%3A26%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20report%20from%20the%20LALA-94%20and%20LALA-SA%20groups%20on%20hypodiploidy%20with%2030%20to%2039%20chromosomes%20and%20near-triploidy:%202%20possible%20expressions%20of%20a%20sole%20entity%20conferring%20poor%20prognosis%20in%20adult%20acute%20lymphoblastic%20leukemia%20(ALL)&rft.jtitle=Blood&rft.au=Charrin,%20Christiane&rft.date=2004-10-15&rft.volume=104&rft.issue=8&rft.spage=2444&rft.epage=2451&rft.pages=2444-2451&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2003-04-1299&rft_dat=%3Cproquest_cross%3E66942739%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c426t-b081e721240871ce15ba653731ce4355336c1adb97db7cab64fe658ac579dacf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=66942739&rft_id=info:pmid/15039281&rfr_iscdi=true